Nutrien (NTR) Q3 Earnings and Revenues Beat Estimates

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

Nutrien (NTR) came out with quarterly earnings of $1.38 per share, beating the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $0.23 per share a year ago. These figures are adjusted for non-recurring items.

– Zacks

This quarterly report represents an earnings surprise of 12.20%. A quarter ago, it was expected that this producer of potash and other fertilizers would post earnings of $2.09 per share when it actually produced earnings of $2.08, delivering a surprise of -0.48%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Nutrien, which belongs to the Zacks Fertilizers industry, posted revenues of $6.02 billion for the quarter ended September 2021, surpassing the Zacks Consensus Estimate by 4.91%. This compares to year-ago revenues of $4.21 billion. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call.

Nutrien shares have added about 45.2% since the beginning of the year versus the S&P 500’s gain of 22.6%.

What’s Next for Nutrien?

While Nutrien has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Nutrien was favorable. While the magnitude and direction of estimate revisions could change following the company’s just-released earnings report, the current status translates into a Zacks Rank #1 (Strong Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $1.49 on $5.37 billion in revenues for the coming quarter and $5.07 on $25.36 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Fertilizers is currently in the top 9% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Infrastructure Stock Boom to Sweep America

A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.

The only question is “Will you get into the right stocks early when their growth potential is greatest?”

Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.

Download FREE: How to Profit from Trillions on Spending for Infrastructure >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Nutrien Ltd. (NTR): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

https://www.entrepreneur.com/article/394730




Fabrinet (FN) Tops Q1 Earnings and Revenue Estimates

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

Fabrinet (FN) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $1.05 per share a year ago. These figures are adjusted for non-recurring items.

– Zacks

This quarterly report represents an earnings surprise of 9.02%. A quarter ago, it was expected that this company that assembles optical, electro-mechanical and electronic devices for other companies would post earnings of $1.22 per share when it actually produced earnings of $1.31, delivering a surprise of 7.38%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Fabrinet, which belongs to the Zacks Electronics – Miscellaneous Components industry, posted revenues of $543.32 million for the quarter ended September 2021, surpassing the Zacks Consensus Estimate by 3.87%. This compares to year-ago revenues of $436.64 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call.

Fabrinet shares have added about 23.7% since the beginning of the year versus the S&P 500’s gain of 22.6%.

What’s Next for Fabrinet?

While Fabrinet has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Fabrinet was mixed. While the magnitude and direction of estimate revisions could change following the company’s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $1.39 on $534.67 million in revenues for the coming quarter and $5.46 on $2.13 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Electronics – Miscellaneous Components is currently in the top 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Infrastructure Stock Boom to Sweep America

A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.

The only question is “Will you get into the right stocks early when their growth potential is greatest?”

Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.

Download FREE: How to Profit from Trillions on Spending for Infrastructure >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Fabrinet (FN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

https://www.entrepreneur.com/article/394731




CVR Energy (CVI) Reports Q3 Loss, Tops Revenue Estimates

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

CVR Energy (CVI) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.96 per share a year ago. These figures are adjusted for non-recurring items.

– Zacks

This quarterly report represents an earnings surprise of -700%. A quarter ago, it was expected that this diversified holding company would post a loss of $0.75 per share when it actually produced a loss of $0.32, delivering a surprise of 57.33%.

Over the last four quarters, the company has surpassed consensus EPS estimates just once.

CVR, which belongs to the Zacks Oil and Gas – Refining and Marketing industry, posted revenues of $1.88 billion for the quarter ended September 2021, surpassing the Zacks Consensus Estimate by 9.65%. This compares to year-ago revenues of $1.01 billion. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call.

CVR shares have added about 28.7% since the beginning of the year versus the S&P 500’s gain of 22.6%.

What’s Next for CVR?

While CVR has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for CVR was mixed. While the magnitude and direction of estimate revisions could change following the company’s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.06 on $1.72 billion in revenues for the coming quarter and -$2 on $6.68 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Oil and Gas – Refining and Marketing is currently in the top 30% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Infrastructure Stock Boom to Sweep America

A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.

The only question is “Will you get into the right stocks early when their growth potential is greatest?”

Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.

Download FREE: How to Profit from Trillions on Spending for Infrastructure >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CVR Energy Inc. (CVI): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

https://www.entrepreneur.com/article/394732




5 Penny Stocks To Watch For November With Potential Biotech Catalysts

This month is an interesting one for penny stocks and blue-chip stocks alike. It marks the official end of the Halloween season and the start of the holidays. November also kicks off the midway part of Q4. But earnings aren’t the only thing that’s going to be at the top of mind right now.

PennyStocks.com – PennyStocks

Certain industries have unique traits and one of these industries is biotechnology. The “unique” part of this is the fact that most companies will announce future dates for investors to be aware of. This could include FDA trial dates, application dates, interim trial data dates or even industry conference presentations. In all cases, biotech investors particularly follow each step or possible instance that a company could reveal pipeline data.

Given the high-stakes make-up of an industry focused on helping mankind live, even the slightest positive or minuscule negative event can dramatically impact a stock. So, if you are looking for penny stocks to buy and biotech is an industry of interest, this is definitely something to keep in mind. Today we’re going to look at 5 penny stocks that have potential biotech catalysts this month. These range from industry presentations to research updates.

Penny Stocks To Watch For November

  1. Tonix Pharmaceuticals (NASDAQ:TNXP)
  2. Liquidia Corporation (NASDAQ:LQDA)
  3. Corvus Pharmaceutiacals (NASDAQ:CRVS)
  4. Agenus (NASDAQ:AGEN)
  5. PhaseBio Pharmaceuticals (NASDAQ:PHAS)

1. Tonix Pharmaceuticals (NASDAQ:TNXP)

One of the lowest-priced penny stocks on this list is Tonix Pharmaceuticals. The company has developed a portfolio made up of treatments targeting immunology and central nervous system diseases. One of the more recent points of focus has been on Tonix’s COVID-19 platform for addressing Long-COVID.

Its TNX-1800 has already reported efficacy data from animal studies in the first quarter of the year with a Phase 1 study to begin during the first half of next year. The company’s COVID treatment pipeline also includes TNX-3500 for treating acute COVID-19, as well as TNX-102 for Long COVID.

Tonix also previously stated that it plans to begin a first-in-human clinical study of its TNX-2100 this quarter pending IND clearance. TNX-2100 is an in vivo diagnostic to measure the presence of functional T cell immunity to COVID.

What To Watch With TNXP Stock In November

This month Tonix gives an oral presentation at the American College of Rheumatology Convergence. The event is held between November 5-9 where Tonix presents on its TNX-102SL. While TNX-102 is being studied in COVID, this presentation will focus on TNX-102SL for treating Fibromyalgia. If TNXP is on your list of penny stocks for November, keep 11/4 on your list. The company’s presentation begins at 11:45 AM ET.

– Top Reddit Penny Stocks to Watch in November 2021

best penny stocks to watch november biotech Tonix Pharmaceuticals TNXP stock chart

2. Liquidia Corporation (NASDAQ:LQDA)

Shares of Liquidia have continued climbing during the fourth quarter. In early October, the company received a favorable ruling in an Inter Partes review against United Therapeutics and its U.S. Patent No. 9,604,901. The ruling found that 7 of the 9 claims were unpatentable. Damian deGoa, President and Chief Executive Officer of Liquidia said: “We are very pleased with this decision by the PTAB. This is a clear win in our on-going patent dispute with United Therapeutics, and we remain confident that we will ultimately prevail on all patent claims they have asserted against us. We will continue to vigorously defend our right to commercialize LIQ861 as soon as possible.”

Liquidia focuses on developing products for pulmonary hypertension and operates through two subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. They act as a uniquely integrated pair with Liquidia Technologies developing the company’s LIQ861, an inhaled dry powder formulation of treprostinil in treating pulmonary arterial hypertension. Meanwhile, Liquidia PAH is the commercialization provider for pharmaceutical products including generic treprostinil injections.

What To Watch With LQDA Stock In November

Now that there’s a bit of background on the company, what’s happening this month that might attract some interest from the market? Earlier this year, the FDA accepted its New Drug Application for the company’s LIQ861. This was actually a resubmission in response to a letter issued in late-2020 that clearly showed the treatment didn’t quite pass the bar. Now, November 7 is the next date to focus on this year. This is the Prescription Drug User Fee Act date given by the Administration.

According to Liquidia’s June update, “If the FDA determines, following its substantive review of the NDA, that all requirements for approval have been met, the FDA may issue tentative approval on a timeline generally informed by the PDUFA goal date.”

best penny stocks to watch november biotech Liquidia Corporation LQDA stock chart

3. Corvus Pharmaceutiacals (NASDAQ:CRVS)

Thanks to COVID-19 becoming a prevalent force in pretty much everything, companies continue working on the development of new treatment candidates. Corvus is another one of the COVID stocks on this list to watch in November. Its lead candidate is CPI-006 (mupadolimab).

– Best Penny Stocks to Buy in November? 3 You Need to Know About

It’s a monoclonal antibody-directed agonist that demonstrated the activation of immune cells in preclinical studies. What’s more, outside of COVID, CPI-006 was combined with other treatments like pembrolizumab – Merck’s (NYSE:MRK) KEYTRUDA – in a Phase 1/1b study in advanced HPV head and neck cancers patients. There’s also a Phase 1b/2 clinical study in HPV+ oropharyngeal cancers and non-small cell lung cancers that haven’t been successfully treated with chemotherapy.

What To Watch With CRVS Stock In November

This month, mupadolimab will be in the spotlight and not for anything related to COVID-19. The company presents new data from its Phase 1b/2 oncology study at the Society for Immunotherapy of Cancer annual meeting. This meeting takes place between November 10-14.

best penny stocks to watch november biotech Corvus Pharmaceuticals CRVS stock chart

4. Agenus (NASDAQ:AGEN)

We’ve discussed Agenus earlier this year just before it went on its epic move out of the penny stock price range. But as is common in biotech, volatility can come especially when data is a core focus. In this case, Agenus was the victim of negative results. In particular, earlier this quarter, the company reported the voluntary withdrawal of its Biologics License Application at the recommendation of the FDA.

Garo Armen, CEO, and Chairman of Agenus explained in more detail that, “While the commercial market for balstilimab monotherapy in second-line cervical cancer was always anticipated to be small, Agenus’ priority remains developing balstilimab as a necessary component of highly effective and affordable combination therapies, both with its own portfolio and with partners, including in combination with Agenus’ next-generation CTLA-4, AGEN1181.”

With this news, the biotech stock dropped from over $5 to under $3.50 at one point. Regardless, November could be an active month for the company as far as events are concerned.

What To Watch With AGEN Stock In November

Next week the company delivers its third-quarter results and business update. On November 9, executives will also host a conference call to discuss everything from the financials to its current model. The company has also scheduled an abstract presentation at the Society for Immunotherapy of Cancer Annual Meeting. On November 12, the company presents its abstract titled, “AGEN1181, an Fc-enhanced anti-CTLA-4 antibody, alone and in combination with balstilimab (anti-PD-1) in patients with advanced solid tumors: Initial phase I results (NCT03860272).”

best penny stocks to watch november biotech Agenus AGEN stock chart

5. PhaseBio Pharmaceuticals (NASDAQ:PHAS)

Similar to LQDA, PHAS stock has been on the move this quarter. Shares have climbed from under $3 to over $4 this week as PhaseBio continues executing on its initiatives. The company is developing therapies for cardiopulmonary diseases.

What To Watch With PHAS Stock In November

Earlier this quarter, it announced PhaseBio’s Phase 3, REVERSE-IT was accepted for presentation at the American Heart Association Scientific Sessions 2021 on November 15. Titled, “Effect of Bentracimab on Platelet Inhibition and Hemostasis in Ticagrelor Patients with Uncontrolled Hemorrhage or Requiring Urgent Surgery in the REVERSE-IT Trial,” the company begins its presentation mid-morning.

While that’s what to watch this month with PHAS stock, it’s also worth mentioning that the company also received a notice of allowance for US Patent titled “Methods and Compositions For Treating Muscle Disease and Disorders.”

With this, PHAS stock saw another surge of momentum late last week. It will be interesting what PhaseBio reports in its presentation at the November conference.

best penny stocks to watch november biotech PhaseBio Pharmaceuticals PHAS stock chart

Best Penny Stocks To Buy [or avoid]

As discussed earlier, certain industries have unique traits all on their own. When it comes to biotechnology, there are always important dates to keep in mind. These are just a few of the many biotech penny stocks with upcoming events to keep in mind this month.

https://www.entrepreneur.com/article/394484




Strong October Ends With New Highs

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

Now that’s a great month! You could almost feel investors letting out a sigh of relief over the past few weeks on the strong start to earnings season (save a couple high profile disappointments). The end result was the S&P putting together its best month of 2021 with record highs for all the major indices.
The NASDAQ was up 0.33% (or about 50 points) today to 15,498.39, while the Dow advanced 0.25% (or around 89 points) to 35,819.56. The S&P increased 0.19% to 4605.38. Not bad considering a couple major earnings misses last night.
But the month of October was much more impressive with the NASDAQ soaring nearly 7.3%, while the S&P was up 6.9% and the Dow rose 5.8%. These totals more than make up for a somber September that saw declines of 4.5% or more.

Plus, the indices all finished today at record highs.
This week was all about the ‘Big 5’ tech players: Apple (AAPL), Amazon (AMZN), Alphabet (GOOG), Facebook (FB) and Microsoft (MSFT). As our Director of Research Sheraz Mian has said, these five companies account for nearly 23% of the total capitalization of the S&P 500 index. Despite the strong monthly totals, these names didn’t all impress (more on that in a moment).
However, the results of earnings season so far suggest that the economy is handling the soaring inflation and severe supply chain issues. These are definitely problems that will hopefully be resolved sooner rather than later, but it hasn’t been the gut punch that many feared.
“Including all the results that came out through Friday, October 29th, we now have Q3 results from 279 S&P 500 members or 55.9% of the index’s total membership,” said Sheraz Mian in his fresh-off-the-presses article titled: “Even Big Tech Has Supply Chain Problems”.
“Total earnings (or aggregate net income) for these 279 companies are up +39.2% from the same period last year on +17.8% lower revenues, with 82.1% beating EPS estimates and 73.5% beating revenue estimates.”
But it hasn’t all been good news, as Sheraz’s title implies. Last night after the bell, AAPL and AMZN fell short of expectations in their quarterly reports. And the aforementioned supply chain issues were a big part of the problem. AMZN was down more than 2% on Friday, while AAPL slipped about 1.8%.
Declines from such major players had an impact in today’s session, but stocks still managed new highs and completed an impressive month. And earnings season is far from over. There are hundreds more reports coming out next week. So have a Happy Halloween and we’ll see you right here again in November.

Today’s Portfolio Highlights:
Headline Trader: While many investors have long considered Twilio (TWLO) as a stock that got too rich too fast, Dan sees it as a market-disrupting AI pioneer with “enormous” earnings potential moving forward. And now that it’s had a post-earnings capitulation, it’s finally within the editor’s wheelhouse. TWLO is a cutting edge automation company that uses AI to provide businesses with effective customer service. Its still unprofitable and very expensive, but its long-term potential is limitless in these “roaring ‘20s”, making this selloff a textbook example of “buying the dip”. TWLO looks like it might experience some springboard price action in the short-term to recover from its plunge and then should be off to the races as more and more businesses realize how indispensable its services are. Make sure you read Dan’s complete commentary on this addition.
Blockchain Innovators: What if Facebook paid you for the ads you were being shown? That’s the idea behind SRAX (SRAX), a digital marketing and consumer data management technology company. It’s BIGtoken platform is a consumer-managed data marketplace where people can own and earn from their data. So this is a company that’s drenched in blockchain technology. The editor really likes its current year forecasts, which call for revenue growth of 262% and earnings growth of 26%. Next year is looking pretty good too and should see the company move into profitability. Dave added SRAX on Friday, while also getting out of “laggard” Funko (FNKO). Read the complete commentary for a lot more on today’s moves. In other news, this portfolio had TWO double-digit winners in the session with A10 Networks (ATEN, +33.6%) and Agilysys (AGYS, +11.4%).
Counterstrike: With earnings coming next week for Roku (ROKU) and Qualys (QLYS), Jeremy decided to play it safe and sell both of these names. ROKU brings a slight loss, but QLYS is an 11.9% profit in less than a month. The new buy is EQT Corp. (EQT), a Zacks Rank #2 (BUY) explorer and producer of natural gas. The company beat the Zacks Consensus Estimate by 340% in its recent quarter, but shares have dipped more than 10% since the report. The editor feels that the stock has a good risk/reward at $20, especially after a positive JPMorgan note this morning. He added EQT on Friday with an 8% allocation. Read the complete commentary for more on all of today’s action, including more on that JPM note.
Surprise Trader: The final addition in this busy week of earnings was Genco Shipping (GNK), a Zacks Rank #1 (Strong Buy) from the drybulk cargo business (top 23% in the Zacks Industry). The company, which has beaten the Zacks Consensus Estimate for three straight quarters, now has a positive Earnings ESP of 3.59% for the quarter coming after the bell on Wednesday, November 3. Dave added GNK on Friday with a 12.5% allocation, while also getting out of Teck Resources (TECK). Read the full write-up for more. Also, this service had one of the biggest winners of the session with SM Energy Corp. (SM) rising 7.2%.
See You in November,
Jim Giaquinto

Recommendations from Zacks’ Private Portfolios:
Believe it or not, this article is not available on the Zacks.com website. The commentary is a partial overview of the daily activity from Zacks’ private recommendation services. If you would like to follow our Buy and Sell signals in real time, we’ve made a special arrangement for readers of this website. Starting today you can see all the recommendations from all of Zacks’ portfolios absolutely free for 7 days. Our services cover everything from value stocks and momentum trades to insider buying and positive earnings surprises (which we’ve predicted with an astonishing 80%+ accuracy). Click here to “test drive” Zacks Ultimate for FREE >>
 
Zacks Investment Research

https://www.entrepreneur.com/article/394442




Rent-A-Center (RCII) Stock Sinks As Market Gains: What You Should Know

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

In the latest trading session, Rent-A-Center (RCII) closed at $53.26, marking a -0.62% move from the previous day. This change lagged the S&P 500’s 0.2% gain on the day.

– Zacks

Coming into today, shares of the company that leases furniture and appliances with an option to buy had lost 4.66% in the past month. In that same time, the Consumer Discretionary sector lost 0.22%, while the S&P 500 gained 5.66%.

Wall Street will be looking for positivity from RCII as it approaches its next earnings report date. This is expected to be November 3, 2021. In that report, analysts expect RCII to post earnings of $1.51 per share. This would mark year-over-year growth of 45.19%. Meanwhile, our latest consensus estimate is calling for revenue of $1.18 billion, up 65.14% from the prior-year quarter.

RCII’s full-year Zacks Consensus Estimates are calling for earnings of $6.26 per share and revenue of $4.61 billion. These results would represent year-over-year changes of +77.34% and +63.91%, respectively.

Investors might also notice recent changes to analyst estimates for RCII. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company’s business outlook.

Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.13% lower within the past month. RCII currently has a Zacks Rank of #3 (Hold).

Valuation is also important, so investors should note that RCII has a Forward P/E ratio of 8.56 right now. This valuation marks a discount compared to its industry’s average Forward P/E of 18.93.

The Consumer Services – Miscellaneous industry is part of the Consumer Discretionary sector. This group has a Zacks Industry Rank of 170, putting it in the bottom 34% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.

Tech IPOs With Massive Profit Potential: Last years top IPOs surged as much as 299% within the first two months. With record amounts of cash flooding into IPOs and a record-setting stock market, this year could be even more lucrative. 

See Zacks’ Hottest Tech IPOs Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
RentACenter, Inc. (RCII): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

https://www.entrepreneur.com/article/394426




Revolve Group (RVLV) Outpaces Stock Market Gains: What You Should Know

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

In the latest trading session, Revolve Group (RVLV) closed at $75.04, marking a +0.58% move from the previous day. The stock outpaced the S&P 500’s daily gain of 0.2%.

– Zacks

Coming into today, shares of the online women’s fashion retailer had gained 20.79% in the past month. In that same time, the Retail-Wholesale sector gained 3.15%, while the S&P 500 gained 5.66%.

Wall Street will be looking for positivity from RVLV as it approaches its next earnings report date. This is expected to be November 3, 2021. On that day, RVLV is projected to report earnings of $0.16 per share, which would represent a year-over-year decline of 40.74%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $217.18 million, up 43.79% from the year-ago period.

For the full year, our Zacks Consensus Estimates are projecting earnings of $1.05 per share and revenue of $828.05 million, which would represent changes of +50% and +42.61%, respectively, from the prior year.

It is also important to note the recent changes to analyst estimates for RVLV. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company’s business outlook.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.36% higher. RVLV currently has a Zacks Rank of #1 (Strong Buy).

Looking at its valuation, RVLV is holding a Forward P/E ratio of 70.87. For comparison, its industry has an average Forward P/E of 57.51, which means RVLV is trading at a premium to the group.

It is also worth noting that RVLV currently has a PEG ratio of 3.42. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company’s expected earnings growth rate into account. The Internet – Commerce industry currently had an average PEG ratio of 2.87 as of yesterday’s close.

The Internet – Commerce industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 166, putting it in the bottom 35% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions.

Tech IPOs With Massive Profit Potential: Last years top IPOs surged as much as 299% within the first two months. With record amounts of cash flooding into IPOs and a record-setting stock market, this year could be even more lucrative. 

See Zacks’ Hottest Tech IPOs Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Revolve Group, Inc. (RVLV): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

https://www.entrepreneur.com/article/394425




Quanta Services (PWR) Stock Sinks As Market Gains: What You Should Know

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

In the latest trading session, Quanta Services (PWR) closed at $121.28, marking a -0.19% move from the previous day. This change lagged the S&P 500’s daily gain of 0.2%.

– Zacks

Prior to today’s trading, shares of the specialty contractor for utility and energy companies had gained 6.76% over the past month. This has outpaced the Construction sector’s gain of 4.44% and the S&P 500’s gain of 5.66% in that time.

Wall Street will be looking for positivity from PWR as it approaches its next earnings report date. This is expected to be November 4, 2021. On that day, PWR is projected to report earnings of $1.47 per share, which would represent year-over-year growth of 5%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $3.43 billion, up 13.5% from the year-ago period.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $4.67 per share and revenue of $12.62 billion. These totals would mark changes of +22.25% and +12.61%, respectively, from last year.

Any recent changes to analyst estimates for PWR should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company’s business outlook.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 1.51% higher. PWR is holding a Zacks Rank of #2 (Buy) right now.

Investors should also note PWR’s current valuation metrics, including its Forward P/E ratio of 26. This valuation marks a premium compared to its industry’s average Forward P/E of 25.89.

The Engineering – R and D Services industry is part of the Construction sector. This industry currently has a Zacks Industry Rank of 96, which puts it in the top 38% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

Tech IPOs With Massive Profit Potential: Last years top IPOs surged as much as 299% within the first two months. With record amounts of cash flooding into IPOs and a record-setting stock market, this year could be even more lucrative. 

See Zacks’ Hottest Tech IPOs Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Quanta Services, Inc. (PWR): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

https://www.entrepreneur.com/article/394427




TimkenSteel (TMST) Outpaces Stock Market Gains: What You Should Know

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

TimkenSteel (TMST) closed the most recent trading day at $13.95, moving +1.68% from the previous trading session. The stock outpaced the S&P 500’s daily gain of 0.2%.

– Zacks

Prior to today’s trading, shares of the maker of steel large bars and seamless mechanical tubing had gained 4.89% over the past month. This has outpaced the Basic Materials sector’s gain of 4.64% and lagged the S&P 500’s gain of 5.66% in that time.

Wall Street will be looking for positivity from TMST as it approaches its next earnings report date. This is expected to be November 4, 2021. In that report, analysts expect TMST to post earnings of $0.66 per share. This would mark year-over-year growth of 273.68%. Meanwhile, our latest consensus estimate is calling for revenue of $330.2 million, up 60.37% from the prior-year quarter.

For the full year, our Zacks Consensus Estimates are projecting earnings of $2.42 per share and revenue of $1.25 billion, which would represent changes of +360.22% and +50.65%, respectively, from the prior year.

Investors should also note any recent changes to analyst estimates for TMST. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company’s business outlook.

Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate has moved 2.02% lower within the past month. TMST currently has a Zacks Rank of #4 (Sell).

Valuation is also important, so investors should note that TMST has a Forward P/E ratio of 5.67 right now. This represents a premium compared to its industry’s average Forward P/E of 4.52.

The Steel – Producers industry is part of the Basic Materials sector. This group has a Zacks Industry Rank of 37, putting it in the top 15% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

Tech IPOs With Massive Profit Potential: Last years top IPOs surged as much as 299% within the first two months. With record amounts of cash flooding into IPOs and a record-setting stock market, this year could be even more lucrative. 

See Zacks’ Hottest Tech IPOs Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Timken Steel Corporation (TMST): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

https://www.entrepreneur.com/article/394429




Star Bulk Carriers (SBLK) Outpaces Stock Market Gains: What You Should Know

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

In the latest trading session, Star Bulk Carriers (SBLK) closed at $20.69, marking a +0.24% move from the previous day. The stock outpaced the S&P 500’s daily gain of 0.2%.

– Zacks

Prior to today’s trading, shares of the shipping company had lost 14.14% over the past month. This has lagged the Transportation sector’s gain of 6.69% and the S&P 500’s gain of 5.66% in that time.

SBLK will be looking to display strength as it nears its next earnings release. In that report, analysts expect SBLK to post earnings of $2.12 per share. This would mark year-over-year growth of 657.14%. Our most recent consensus estimate is calling for quarterly revenue of $406.04 million, up 102.79% from the year-ago period.

SBLK’s full-year Zacks Consensus Estimates are calling for earnings of $6.53 per share and revenue of $1.37 billion. These results would represent year-over-year changes of +3741.18% and +96.98%, respectively.

Any recent changes to analyst estimates for SBLK should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company’s business outlook.

Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 11.03% higher. SBLK is currently sporting a Zacks Rank of #2 (Buy).

Investors should also note SBLK’s current valuation metrics, including its Forward P/E ratio of 3.16. This valuation marks a discount compared to its industry’s average Forward P/E of 4.66.

The Transportation – Shipping industry is part of the Transportation sector. This industry currently has a Zacks Industry Rank of 57, which puts it in the top 23% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.

Tech IPOs With Massive Profit Potential: Last years top IPOs surged as much as 299% within the first two months. With record amounts of cash flooding into IPOs and a record-setting stock market, this year could be even more lucrative. 

See Zacks’ Hottest Tech IPOs Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Star Bulk Carriers Corp. (SBLK): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

https://www.entrepreneur.com/article/394428